Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Completed

The Canada Lymph Node Score Project: A Crossover Trial

NCT04342377

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Royal Alexandra Hospital Edmonton, Alberta, Canada
  • Health Sciences Centre Winnipeg, Manitoba, Canada
  • St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details
Completed

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

NCT00347412

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Northern Indiana Cancer Research Consortium South Bend, Indiana, United States
View all 75 locations
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

NCT02071862

Conditions
Adenocarcinoma, Adenoma, Breast Diseases, +38 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

NCT02648724

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 27 locations
View Trial Details
Completed

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

NCT02684461

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UNC Lineberger Comprehsive Cancer Center Chapel Hill, North Carolina, United States
  • Rex Cancer Center Raleigh, North Carolina, United States
  • Rex Cancer Center of Wakefield Raleigh, North Carolina, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive

NCT03790397

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ICO Badalona Badalona, Barcelona, Spain
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, Galicia, Spain
  • Complejo Hospitalario Universitario A Coruña A Coruña, La Coruña, Spain
  • Hospital Universitario Dr. Negrín Las Palmas de Gran Canaria, Las Palmas, Spain
View all 31 locations
View Trial Details
Completed

Dose Individualization of Pemetrexed - IMPROVE-III

NCT03655834

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • Antoni van Leeuwenhoek Amsterdam, Netherlands
  • Maastricht University Medical centre Maastricht, Netherlands
  • Radboud university medical centre Nijmegen, Netherlands
View Trial Details

Related conditions